Aegis Keeps BioLineRx (BLRX) at 'Buy'; Plenty of Catalysts Happening Over Next 12 Months
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.04 -0.02 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $1.63 | |||
| Open | $2.04 | 52 Week Low | $0.71 | |||
| Day High | $2.04 | P/E | N/A | |||
| Day Low | $2.04 | EPS | $0.00 | |||
| Volume | 359 | |||||
